| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic Dialysis |
1 Induces Epithelial Mesenchymal Transition in the Rodent Peritoneum





* Division of Nephrology and
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; and
Renal Division Scientific Affairs, Baxter Healthcare Corporation, McGaw Park, Illinois
Address correspondence to: Dr. Peter J. Margetts, Department of Medicine, McMaster University, Division of Nephrology, Street Josephs Hospital, 50 Charl-ton Avenue E, Hamilton, Ontario, Canada, L8P 4A6. Phone: 905-522-1155; Fax: 905-521-6068; E-mail: margetts{at}mcmaster.ca
| Abstract |
|---|
|
|
|---|
1-induced peritoneal fibrosis is reported. Sprague-Dawley rats received an intraperitoneal injection of an adenovirus vector that transfers active TGF-
1 (AdTGF-
1) or control adenovirus, AdDL. Animals were killed 0 to 21 days after infection. Peritoneal effluent and tissue were analyzed for markers of EMT. In the animals that were treated with AdTGF-
1, an increase in expression of genes associated with EMT and fibrosis, such as type I collagen A2,
-smooth muscle actin, and the zinc finger regulatory protein Snail, was identified. Transition of mesothelial cells 4 to 7 d after infection, with appearance of epithelial cells in the submesothelial zone 7 to 14 d after exposure to AdTGF-
1, was demonstrated. This phase was associated with disruption of the basement membrane and increased expression of matrix metalloproteinase 2. By 14 to 21 d after infection, there was evidence of restoration of normal submesothelial architecture. These findings suggest that EMT occurs in vivo after TGF-
1 overexpression in the peritoneum. Cellular changes and gene regulation associated with EMT are evident throughout the fibrogenic process and are not limited to early time points. This further supports the central role of TGF-
1 in peritoneal fibrosis and provides an important model to study the sequence of events involved in TGF-
1-induced EMT. | Introduction |
|---|
|
|
|---|
1 (7), and recently, in vivo evidence was found for EMT in patients who are on peritoneal dialysis (PD) (8). The steps in EMT include a loss of cell-cell and cell-matrix interaction through downregulation of E-cadherin and
-catenin (1,9), migration, basement membrane degradation through matrix metalloproteinase-2 (MMP-2) (10), and cytoskeletal rearrangement with expression of
-smooth muscle actin (
-SMA) (11), all events that are a normal part of tissue repair but could also contribute to chronic fibrosis. In fibrotic disorders, the myofibroblast has been identified as one of the major cellular components involved in collagen deposition, and its presence correlates with progression of the disease (12). The origin of the myofibroblast has not been clearly defined, but recent studies in bone marrow chimeric mice confirm the role of mesenchymal transition over recruitment of circulating cell populations as the precursors of interstitial myofibroblasts (13).
Peritoneal fibrosis is a ubiquitous process in patients who are on PD (14). The importance of mild peritoneal fibrosis is uncertain, but we have previously shown an association between fibrogenesis and angiogenesis in the peritoneum after exposure to TGF-
1 (15). Increased vascular surface area of the peritoneum has been hypothesized to increase solute transport and lead to ultrafiltration dysfunction in PD patients (16). Encapsulating peritoneal sclerosis is a rare but devastating fibrotic complication seen in a variety of settings including PD (17). Therefore, peritoneal fibrosis is a potential severe limitation for patients who are reliant on PD for renal replacement therapy.
In this study, we induced peritoneal fibrosis using adenovirus-mediated gene transfer of active TGF-
1 to the rat peritoneum and analyzed peritoneal tissue at early (days 1 to 4 after infection) and later (days 7, 14, and 21) time points to identify markers of EMT. We observed an early increased expression of the EMT-related regulatory protein Snail along with increased expression of
-SMA, MMP-2, and type I collagen gene expression. In tissue sections, using dual-labeled immunofluorescence, we identified an early increase in dual-staining
-SMA and cytokeratin-positive cells in the mesothelial cell layer, with an increase in
-SMA-positive cells immediately beneath the mesothelial cells. At later time points, we could identify cells with both epithelial and myofibroblast characteristics within the submesothelial tissue. There was evidence of migration of cells through a disrupted basement membrane structure. It is interesting that, in vivo, we found increased gene and protein expression of E-cadherin, which is opposite to what we and others have found in in vitro experiments.
This study supports the role of EMT in peritoneal fibrosis and confirms the role of TGF-
1 in this process. In vivo models of EMT are not readily available, and this simple model allows the identification of the temporal sequence of TGF-
1-induced EMT and will allow further research into this important physiologic event.
| Materials and Methods |
|---|
|
|
|---|
1 has been previously described (18). AdTGF-
1 was created with TGF-
1 cDNA mutated at residues 223 and 225 so that the transgene product does not bind to the latency-associated protein and therefore is biologically active. To control for adenovirus effects, a null adenovirus (AdDL) was used (19). Adenovirus preparations were purified by CsCl gradient centrifugation and PD-10 Sephadex chromatography (Amersham Pharmacia, Baie dUrfe, PQ, Canada) and plaque titered on 293 cells as described previously (20).
Animals.
All animal studies were carried out according to the Canadian Council on Animal Care Guidelines. Two groups of female Sprague-Dawley rats (Harlan, Indianapolis, IN) that weighed 200 to 250 g received an intraperitoneal injection of AdTGF-
1 (n = 46) or control adenovirus (n = 21). All were administered adenovirus at a dose of 1.5 x 109 plaque-forming units (pfu)/ml diluted to 100 µl in PBS on day 0. No attempt was made to block the anti-adenoviral inflammatory response. This dose was similar to that used in previous experiments (15). Animals that were infected with AdTGF-
1 were killed on days 1 to 4, 7, 14, or 21 after adenovirus administration. AdDL-treated animals were killed on days 1 to 4, or 21. At early time points (days 1 to 3), four animals per group were killed. At later time points (days 4 to 21), 6 to 10 animals were killed. A third group of naïve rats (n = 6) were killed for control. Before the rats were killed, 0.09 ml/g 2.5% Dianeal (Baxter Healthcare, McGaw Park, IL) was administered intraperitoneally. Four hours later, the animal was killed, the peritoneum was opened, and the entire fluid content was removed. The entire anterior abdominal wall was removed after skin and subcutaneous tissues were removed. The lower or caudal portion of this tissue was stored in 4% neutral-buffered formalin, and the upper or rostral portion was taken for RNA extraction. Omental tissue was taken and frozen in liquid nitrogen.
Cell Culture
Primary mesothelial cells were isolated from rat peritoneum as described previously (15). Briefly, the anterior abdominal wall from naïve rats was isolated, washed with PBS, and covered with 10% trypsin (Invitrogen, Burlington, ON, Canada) for 45 min. The trypsin was then removed and centrifuged, and the cell pellet was resuspended in F12 medium supplemented with 10% FCS, 1% penicillin/streptomycin, and 0.08% Fungizone (Invitrogen). Cells were grown to confluence in six-well plates and then rested for 12 h in medium with 1% FCS. Cells then were exposed to varying concentrations of recombinant TGF-
1 (R&D Systems, Minneapolis, MN). Cell cultures had typical cobblestone appearance on phase contrast microscopy. Each culture condition was repeated in triplicate, and the entire experiment was repeated in duplicate.
Histology
Tissue samples from the lower portion of the anterior abdominal wall were fixed in 10% buffered formalin for 24 h. These samples then were processed and paraffin embedded, and sections were cut at 5 µm. Sections then were stained for Massons trichrome or processed for immunohistochemistry using antibodies against
-SMA or laminin (Dako Corp., Carpinteria, CA) (15).
Dual staining with antibodies to
-SMA and cytokeratin (B&D Bioscience) was performed using fluorescently labeled antibodies. After antigen retrieval in boiling 10 mM citrate buffer (pH 6.0) for 45 min, sections were incubated with
-SMA antibody followed by a secondary rabbit anti-mouse antibody labeled with Texas Red (Molecular Probes, Eugene, OR). Sections then were stained with a FITC-labeled antibody to cytokeratin (Sigma Chemicals, Oakville, ON, Canada) and mounted with a DAPI nuclear stain (Vectashield, Vector Technologies). After the same antigen retrieval process, single staining with a FITC-labeled anti-E-cadherin antibody (B&D Bioscience) was also performed. These sections were viewed with a Leica DMR fluorescence microscope (Leica Microsystems, Wetzlar, Germany). Negative control sections were run in parallel with nonimmune mouse or rabbit serum for immunohistochemistry and immunofluorescence staining.
Anterior abdominal wall tissue was fixed in 2% glutaraldehyde in sodium cacodylate buffer (pH 7.4) for 24 h. The tissue then was rinsed in sodium cacodylate buffer, postfixed in 1% osmium tetroxide for 1 h, dehydrated in graded ethanol solutions, and embedded in Spurrs resin. Ultrathin sections (90 nm) were cut and placed on a 200-mesh thin bar copper grid and stained with uranyl acetate and lead citrate. The specimens were examined with a Philips CM10 transmission electron microscope.
Quantitative PCR
mRNA was extracted from the peritoneum of killed animals by immersing the parietal peritoneal surface in Trizol reagent (Invitrogen) for 20 min. Histologic analysis of tissues after Trizol exposure indicated that RNA was extracted predominantly from mesothelial and submesothelial tissue with little involvement of the submesothelial skeletal muscle (data not shown). For mesothelial cell culture experiments, confluent cells in six-well plates, exposed to recombinant TGF-
1, were lysed in Trizol. RNA was extracted from Trizol according to the manufacturers instruction. RNA integrity and concentration were determined with an Agilent 2100 bioanalyzer (Agilent Technologies, Missisauga, ON, Canada). RNA (1 µg) then was DNAse treated and reverse-transcribed using a standard protocol (Invitrogen). Quantitative real-time PCR for Snail, MMP-2 type 1 collagen A2 (COL1A2), E-cadherin, and
-SMA was carried out using an ABI Prism 7700 Sequence Detector (Applied Biosystems, Foster City, CA). Pooled mRNA from control animals was used to create a standard curve for comparative quantification. The correlation coefficient for the standard curves all were >0.90. Samples were run in duplicate and multiplexed with glyceraldehyde-3-phosphate dehydrogenase probe and primer (Applied Biosystems). Negative control samples (no template or no reverse transcriptase) were run concurrently. Primers (Mobix, Hamilton, ON, Canada) and probes (Applied Biosystems) are shown in Table 1. Target gene probes were labeled with FAM reporter, and housekeeping gene probe was labeled with VIC. Similar results were observed referenced to either glyceraldehyde-3-phosphate dehydrogenase or 18S. Results are reported as relative to 18S RNA.
|
using commercially available ELISA kits (R&D Systems). MMP-2 content in the peritoneal effluent was studied using zymography. Equal volumes of peritoneal fluid were separated using 12% SDS-PAGE with the addition of gelatin (1 mg/ml; Sigma Chemicals). The gel was incubated in a solution of 2.5% Triton X-100 (Sigma Chemicals) for 30 min, incubated overnight at 37°C in an activating buffer (50 mM Tris-HCl [pH 8], 10 mM CaCl2, 150 nm ZnSO4, and 150 mM NaCl), stained with Coomassie Brilliant Blue R250 (Bio-Rad, Mississauga, ON, Canada) for 30 min and destained in a solution of 7.5% acetic acid and 5% methanol. MMP-2 and -9 standards were run concurrently (Chemicon, Temecula, CA).
Western Blot
Protein was extracted from frozen omental peritoneal tissue by homogenization in a standard lysis buffer with addition of proteinase inhibitors (sodium orthovanadate, phenylmethylsulfonyl fluoride, leupeptin, and aprotinin; all from BioShop, Burlington, ON, Canada), Twenty micrograms was electrophoresed on an 12% SDS-PAGE gel, transferred to a nylon membrane, and probed with an antibody to E-cadherin (BD Biosciences, Mississauga, ON, Canada). E-cadherin protein was visualized with enhanced chemiluminescences detection (Amersham Biotech, Piscataway, NJ).
Statistical Analyses
Data are presented as mean ± SD. Comparison between groups was made by independent t test. P < 0.05 was considered to be significant, and all tests were two-tailed.
| Results |
|---|
|
|
|---|
1 induced a transient, mild peritonitis characterized by an approximately 10-fold increase in peritoneal effluent concentrations of TNF-
3 d after adenoviral infection (Table 2). There was an associated increase in peritoneal effluent cellularity (Table 2) that was predominantly neutrophilic. These measures of peritoneal inflammation all resolved back to baseline by day 4 after adenoviral infection.
|
1 was also essential for EMT in this model.
|
1 Induces Peritoneal Fibrosis
1 induces a potent peritoneal fibrosis. In the present study, we confirmed that there was an induction of fibrosis as early as 4 d after exposure to TGF-
1, by both histologic evaluation (Figure 1C) and quantitative real-time PCR for COL1A2 (Figure 2B). Gene expression of COL1A2 and
-SMA (Figure 2A) was maximal at day 4 and declined back to baseline by day 21.
|
1-Induced EMT in Peritoneal Tissues
1. There was a significant increase in mRNA and protein expression of
-SMA (Figures 2A and 3), as well as an increase in Snail gene expression (Figure 2C). Changes in expression of this EMT-related gene persisted to day 21.
|
-SMA in the submesothelial tissue of the peritoneal membrane (Figure 3). Four days after infection with AdTGF-
1, immunofluorescence demonstrated the appearance of dual-labeled cytokeratin and
-SMA-positive cells within the mesothelial cell layer (Figure 4, A through C). At days 7 and 14, cytokeratin-positive epithelial cells were found within the submesothelial tissue and were intermingled with
-SMA-positive myofibroblasts (Figure 4, D through I). Dual-labeled cytokeratin and
-SMA-positive cells were also observed at day 7 within the interstitium but were not seen at day 14 (Figure 4, D through I). Electron microscopy revealed the presence of fibroblasts migrating through a basement membrane structure by day 4 (Figure 5B). The presence of myofibroblasts was confirmed by ultrastructural examination of peritoneal tissue 7 d after infection with AdTGF-
1 (Figure 5, C and E). There was direct evidence at days 4 and 7 on immunofluorescence (Figure 4, A through F) of EMT with cells staining for both cytokeratin and
-SMA. This was also suggested by electron microscopy, with mesothelial cells showing the development of probable intracellular microfilaments (Figure 5D). There was evidence of loss of an intact mesothelial cell layer in dual-labeled sections (Figures 4, D through I, and 5C) 7 and 14 d after infection with AdTGF-
1. Fluorescence and ultrastructural studies suggested that migratory behavior, cellular transition, and loss or detachment of mesothelium were maximal at day 7 after AdTGF-
1 infection. By day 21, there was resolution of these changes suggestive of EMT with evidence of re-mesothelialization (Figure 4J). There was no induced expression of
-SMA or observed myofibroblasts in AdDL-treated animals (Figures 4K and 5A) or in untreated control animals.
|
|
1-Induced EMT
1, laminin expression was significantly increased, with the basement membrane structure now appearing several cells deep beneath the mesothelial layer (Figure 6B). By electron microscopy, fibroblasts can be observed moving through this basement membrane structure (Figure 5B). By day 7, there was cellular expansion both above and below the basement membrane structure, loss of continuity, and transit of cells and blood vessels through this structure (Figure 6, C and D). By day 14, there was a new basement membrane formed beneath the re-epithelialized peritoneal surface, with traces of the original basement membrane identified 50 to 100 µm beneath the new peritoneal surface (Figure 6E). Ultrastructural studies of peritoneal samples 14 d after infection with AdTGF-
1 suggest that submesothelial fibroblasts are involved in the creation of the new basement membrane (Figure 5F). This progressive destruction of the original basement membrane histologically occurs between days 4 and 14 after AdTGF-
1 infection and corresponds to the increased gene and protein expression of MMP-2 (Figure 7).
|
|
1 Induces Increased Expression of E-Cadherin
1 demonstrated increased protein expression of E-cadherin with increase in gene expression 2 to 7 d after adenoviral infection (Figure 8). Protein and cellular localization (Figure 8, B and C) suggests an increase in both E-cadherin-expressing cells and E-cadherin gene expression (Figure 8A). E-cadherin expression in response to TGF-
1 was evaluated in primary culture mesothelial cells. In keeping with previous in vitro experiments (6), E-cadherin gene expression was downregulated by exposure to recombinant TGF-
1 in a dose-responsive manner (Figure 9). This was associated with a moderate increase in Snail gene expression. There was the expected fibrogenic response in vitro with upregulation of collagen and
-SMA gene expression.
|
|
| Discussion |
|---|
|
|
|---|
1 using adenovirus-mediated gene transfer leads to a persisting peritoneal fibrosis with associated angiogenesis and functional changes (15). Recent observations that EMT is involved in peritoneal fibrosis (8) and that mesothelial cells undergo EMT in response to TGF-
1 (7) led us to study the rat peritoneum after overexpression of TGF-
1 and evaluate for markers suggestive of EMT.
Our findings are strongly suggestive of the occurrence of EMT after AdTGF-
1 infection, and we have been able to characterize the sequence of events associated with TGF-
1-induced EMT. The presence of cytokeratin/
-SMA-positive cells in the mesothelium 4 d after infection with AdTGF-
1 is strong evidence of EMT. We cannot rule out that some of the
-SMA-positive submesothelial cells may be transformed fibroblasts or other cell types recruited locally or from the circulation. Snail mRNA was upregulated in the peritoneum early and coincident with evidence of EMT (day 2 after infection with AdTGF-
1).
-SMA and collagen gene expression increased by 2 d after infection, with histologic evidence of
-SMA-positive cells in the submesothelial tissue 3 d after infection.
The peak of activity occurred by day 7 with direct evidence of transitional cells with both epithelial and myofibroblast phenotype. There was extensive cellular proliferation, migration, structural re-organization, and loss of epithelial cell adhesion and continuity. MMP-2 was shown recently to be an essential component of EMT in renal tubular epithelial cells (21). Our experiments confirm that TGF-
1 upregulates MMP-2 mRNA expression and MMP-2 protein as measured by zymography. Associated with this increase in MMP-2 expression was evidence of destruction of basement membrane and movement of cells across this barrier. It is interesting that between days 7 and 14, myofibroblasts and epithelial cells were found intermingled in the submesothelial tissue.
By day 14, there was evidence that the period of destruction and rearrangement was resolving. Myofibroblasts were less evident by electron microscopy; however,
-SMA-positive cells persisted. The mesothelial integrity was again evident by day 21, with the creation of a new submesothelial basement membrane structure evident at day 14 after infection. This resolution coincides with a decrease in the gene expression of the fibrogenic cytokines
-SMA and collagen.
We evaluated the expression of Snail and E-cadherin, molecules previously implicated in EMT. Snail is a zinc finger regulator of gene expression that is upregulated in EMT (22) and seems to inhibit the mRNA expression of E-cadherin (23). We did observe increased expression of Snail mRNA early after TGF-
1 exposure both in vivo and in mesothelial cell culture. This is in agreement with the role of Snail as an early regulator of EMT. In previous work in vitro, it was observed that this increased expression of Snail inhibits E-cadherin mRNA expression and thus inhibits this important intercellular adhesion molecule (10). This loss of intercellular adhesion is a key step in EMT and allows for further transformation and migration of the affected epithelial cell (9). We confirmed that in cell culture, using our PCR assay methods, we did find a clear suppression of E-cadherin gene expression after exposure to TGF-
1, as has been described previously (6).
It is interesting that, in vivo, we observed an effect opposite to what was expected. E-cadherin protein expression was increased after AdTGF-
1 infection, with a modest increase in E-cadherin mRNA that occurred between day 2 and day 7 with a return to baseline by day 14. This is despite histologic evidence for loss of adhesion of the mesothelial cell layer during this time. This discordance between the in vivo and in vitro regulation of E-cadherin was observed previously. Previous work in radiation induced lung fibrosis demonstrated increased immunostaining for E-cadherin in damaged lung tissue (24). We believe that the discrepancy between the in vivo and in vitro findings concerning E-cadherin likely occurs because of the effects of the local in vivo environment on epithelial cells. Specifically, it seems that E-cadherin-positive epithelial cells proliferate in peritoneal tissue in response to TGF-
1, increasing E-cadherin protein expression. It is also possible that TGF-
1 may positively regulate E-cadherin expression through interaction with extracellular matrix (25) and through the signaling pathway molecule SMAD4 (26), as has been described in recent publications. Clearly, this discrepant finding of E-cadherin expression warrants further investigation.
As we studied early time points after peritoneal adenovirus infection, we also evaluated peritoneal effluent and tissue for evidence of adenovirus-related inflammation. There was clearly an inflammatory response to both the control adenovirus and AdTGF-
1 that reached maximal expression 3 d after infection. This inflammatory response was no longer evident by day 4. More important, aside from a minor regulation in MMP-2 likely induced by inflammation, other markers of EMT and fibrosis were not regulated during this early inflammatory response. This indicates that TGF-
1 overexpression is responsible for the early fibrogenic changes that we observed.
In these studies, we see a general agreement between changes in mRNA expression and protein expression on the basis of immunoblot or immunohistochemistry. Specifically, there was a good temporal correlation between the immunohistochemical appearance of
-SMA-positive cells and increased mRNA expression (Figures 2 and 3). However, the correlation was not as precise between MMP-2 and E-cadherin gene and protein expression (Figures 7 and 8). This is in agreement with studies comparing genome- and proteome-wide scanning that demonstrate reasonable protein-gene correlation in large categories but poor correlation at the individual protein-gene level (27). It is interesting that this study demonstrated the poorest correlation between genes and proteins involved in cellular organization (27).
In summary, we provide further evidence that TGF-
1 induces peritoneal fibrosis, and this fibrogenesis is associated with induction of EMT. Furthermore, we have direct histologic evidence that this process occurs at an early time point and persists for at least 14 d after exposure to TGF-
1. There are few, if any, models of in vivo EMT. With this model, we have identified the temporal pattern of EMT and have observed discrepancies between the well studied in vitro and this in vivo response to overexpression of TGF-
1. With this model, we cannot assess other important causes of peritoneal damage seen in patients on PD, including uremia, glucose, glucose degradation products, and low pH. This model will allow for further evaluation of this important physiologic process and assessment of therapeutic intervention aimed at preventing peritoneal fibrosis.
| Acknowledgments |
|---|
This work was presented previously as an abstract at the American Society of Nephrology Meeting, November 1417, 2003.
We thank Mary Jo Smith, Jessica Thoma, Cheri Bethune, Duncan Chong, and Xueya Feng for technical support.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
ligand requirements during mouse and avian endocardial cushion morphogenesis.
Dev Biol 248
: 170
181, 2002[CrossRef][Medline]
1 to the rat peritoneum: Effects on membrane function.
J Am Soc Nephrol 12
: 2029
2039, 2001
1 induces prolonged severe fibrosis in rat lung.
J Clin Invest 100
: 768
776, 1997[Medline]
This article has been cited by other articles:
![]() |
R. Vargha, T. O. Bender, A. Riesenhuber, M. Endemann, K. Kratochwill, and C. Aufricht Effects of epithelial-to-mesenchymal transition on acute stress response in human peritoneal mesothelial cells Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3494 - 3500. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hirahara, Y. Ishibashi, S. Kaname, E. Kusano, and T. Fujita Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats Nephrol. Dial. Transplant., September 12, 2008; (2008) gfn495v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cina, P. Patel, J. C. Bethune, J. Thoma, J. C. Rodriguez-Lecompte, C. M. Hoff, L. Liu, and P. J. Margetts Peritoneal morphological and functional changes associated with platelet-derived growth factor B Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn498v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishimura, Y. Ito, M. Mizuno, A. Tanaka, Y. Morita, S. Maruyama, Y. Yuzawa, and S. Matsuo Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1084 - F1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Decologne, M. Kolb, P. J. Margetts, F. Menetrier, Y. Artur, C. Garrido, J. Gauldie, P. Camus, and P. Bonniaud TGF-beta1 Induces Progressive Pleural Scarring and Subpleural Fibrosis J. Immunol., November 1, 2007; 179(9): 6043 - 6051. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guo, J. C.K. Leung, M. F. Lam, L. Y.Y. Chan, A. W.L. Tsang, H. Y. Lan, and K. N. Lai Smad7 Transgene Attenuates Peritoneal Fibrosis in Uremic Rats Treated with Peritoneal Dialysis J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2689 - 2703. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Aroeira, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, G. del Peso, J. A. Jimenez-Heffernan, R. Selgas, and M. Lopez-Cabrera Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2004 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vargha, M. Endemann, K. Kratochwill, A. Riesenhuber, N. Wick, A.-M. Krachler, L. Malaga-Dieguez, and C. Aufricht Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2943 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. De Vriese, R. G. Tilton, S. Mortier, and N. H. Lameire Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2549 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barrallo-Gimeno and M. A. Nieto The Snail genes as inducers of cell movement and survival: implications in development and cancer Development, July 15, 2005; 132(14): 3151 - 3161. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |